Clinical Trials
7 trialsNCT01049620 2020-01-07
RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX
Asan Medical Center
Phase 1 Completed
NCT01471470 2020-01-07
Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer
Asan Medical Center
Phase 2 Completed
NCT00842491 2015-05-19
Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer
Peking University
Phase 2 Completed
NCT01015339 2015-05-19
Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
Peking University
Phase 3 Unknown
NCT02071043 2014-02-25
Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis
Shanghai Zhongshan Hospital
Phase 2 Completed
NCT02038621 2014-01-16
GZH-001
The Second People's Hospital of Sichuan
Phase 2 Unknown
NCT00743964 2010-01-15
Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)
Samsung Medical Center
Phase 2 Completed